About
Redshift Bio develops technology for analyzing proteins and biomolecules to detect subtle structural changes using Microfluidic Modulation Spectroscopy, enabling bioprocess analytics and biophysical characterization relevant for drug and vaccine development.
Explore Redshift Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.